Alpha radiation retreatment shows promise for returning cancers
NCT ID NCT04540588
First seen Jan 10, 2026 · Last updated May 20, 2026 · Updated 22 times
Summary
This study tested whether a second round of a special alpha radiation treatment (DaRT) is safe and effective for people with skin, mouth, or soft tissue cancers that came back after the first treatment. Only 2 participants were enrolled. The treatment involves placing tiny radiation seeds directly into the tumor. The goal was to shrink the tumor and track any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKIN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sharett institute, Hadassah University Hospital - Ein-Kerem
Jerusalem, 91120, Israel
Conditions
Explore the condition pages connected to this study.